Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sub-tonsillar bupivacaine injection for postoperative nausea and vomiting after tonsillectomy
IRCT20191016045134N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jan 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bupivacaine and epinephrine in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Pain intensity at 24 hours, Nausea score at 24 hours and 2 more. Started Jan 2020; status: completed.
02
Drugs
bupivacaineepinephrine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20191016045134N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191016045134N1.